Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pediatric Medicines Market Growth 2022-2028

  • LP 4841999
  • 109 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Pediatric Medicines will have significant change from previous year. According to our (LP Information) latest study, the global Pediatric Medicines market size is USD million in 2022 from USD 99890 million in 2021, with a change of % between 2021 and 2022. The global Pediatric Medicines market size will reach USD 133800 million in 2028, growing at a CAGR of 4.3% over the analysis period.

The United States Pediatric Medicines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pediatric Medicines market, reaching US$ million by the year 2028. As for the Europe Pediatric Medicines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Pediatric Medicines players cover GSK, Novartis, Pfizer, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Medicines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Enteral

Parenteral

Topical

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinic

Family

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GSK

Novartis

Pfizer

Sanofi

Abbott

Bristol-Myers Squibb

Cipla

Eisai Pharmaceuticals

Eli Lilly

F. Hoffman-La Roche

Glenmark

Helsinn Healthcare

Heron Therapeutics

Ipca Laboratories

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pediatric Medicines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pediatric Medicines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pediatric Medicines by Country/Region, 2017, 2022 & 2028

2.2 Pediatric Medicines Segment by Type

2.2.1 Enteral

2.2.2 Parenteral

2.2.3 Topical

2.3 Pediatric Medicines Sales by Type

2.3.1 Global Pediatric Medicines Sales Market Share by Type (2017-2022)

2.3.2 Global Pediatric Medicines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pediatric Medicines Sale Price by Type (2017-2022)

2.4 Pediatric Medicines Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Family

2.5 Pediatric Medicines Sales by Application

2.5.1 Global Pediatric Medicines Sale Market Share by Application (2017-2022)

2.5.2 Global Pediatric Medicines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pediatric Medicines Sale Price by Application (2017-2022)

3 Global Pediatric Medicines by Company

3.1 Global Pediatric Medicines Breakdown Data by Company

3.1.1 Global Pediatric Medicines Annual Sales by Company (2020-2022)

3.1.2 Global Pediatric Medicines Sales Market Share by Company (2020-2022)

3.2 Global Pediatric Medicines Annual Revenue by Company (2020-2022)

3.2.1 Global Pediatric Medicines Revenue by Company (2020-2022)

3.2.2 Global Pediatric Medicines Revenue Market Share by Company (2020-2022)

3.3 Global Pediatric Medicines Sale Price by Company

3.4 Key Manufacturers Pediatric Medicines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pediatric Medicines Product Location Distribution

3.4.2 Players Pediatric Medicines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pediatric Medicines by Geographic Region

4.1 World Historic Pediatric Medicines Market Size by Geographic Region (2017-2022)

4.1.1 Global Pediatric Medicines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pediatric Medicines Annual Revenue by Geographic Region

4.2 World Historic Pediatric Medicines Market Size by Country/Region (2017-2022)

4.2.1 Global Pediatric Medicines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pediatric Medicines Annual Revenue by Country/Region

4.3 Americas Pediatric Medicines Sales Growth

4.4 APAC Pediatric Medicines Sales Growth

4.5 Europe Pediatric Medicines Sales Growth

4.6 Middle East & Africa Pediatric Medicines Sales Growth

5 Americas

5.1 Americas Pediatric Medicines Sales by Country

5.1.1 Americas Pediatric Medicines Sales by Country (2017-2022)

5.1.2 Americas Pediatric Medicines Revenue by Country (2017-2022)

5.2 Americas Pediatric Medicines Sales by Type

5.3 Americas Pediatric Medicines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pediatric Medicines Sales by Region

6.1.1 APAC Pediatric Medicines Sales by Region (2017-2022)

6.1.2 APAC Pediatric Medicines Revenue by Region (2017-2022)

6.2 APAC Pediatric Medicines Sales by Type

6.3 APAC Pediatric Medicines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pediatric Medicines by Country

7.1.1 Europe Pediatric Medicines Sales by Country (2017-2022)

7.1.2 Europe Pediatric Medicines Revenue by Country (2017-2022)

7.2 Europe Pediatric Medicines Sales by Type

7.3 Europe Pediatric Medicines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pediatric Medicines by Country

8.1.1 Middle East & Africa Pediatric Medicines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pediatric Medicines Revenue by Country (2017-2022)

8.2 Middle East & Africa Pediatric Medicines Sales by Type

8.3 Middle East & Africa Pediatric Medicines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pediatric Medicines

10.3 Manufacturing Process Analysis of Pediatric Medicines

10.4 Industry Chain Structure of Pediatric Medicines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pediatric Medicines Distributors

11.3 Pediatric Medicines Customer

12 World Forecast Review for Pediatric Medicines by Geographic Region

12.1 Global Pediatric Medicines Market Size Forecast by Region

12.1.1 Global Pediatric Medicines Forecast by Region (2023-2028)

12.1.2 Global Pediatric Medicines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pediatric Medicines Forecast by Type

12.7 Global Pediatric Medicines Forecast by Application

13 Key Players Analysis

13.1 GSK

13.1.1 GSK Company Information

13.1.2 GSK Pediatric Medicines Product Offered

13.1.3 GSK Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GSK Main Business Overview

13.1.5 GSK Latest Developments

13.2 Novartis

13.2.1 Novartis Company Information

13.2.2 Novartis Pediatric Medicines Product Offered

13.2.3 Novartis Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis Main Business Overview

13.2.5 Novartis Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Pediatric Medicines Product Offered

13.3.3 Pfizer Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Sanofi

13.4.1 Sanofi Company Information

13.4.2 Sanofi Pediatric Medicines Product Offered

13.4.3 Sanofi Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sanofi Main Business Overview

13.4.5 Sanofi Latest Developments

13.5 Abbott

13.5.1 Abbott Company Information

13.5.2 Abbott Pediatric Medicines Product Offered

13.5.3 Abbott Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Abbott Main Business Overview

13.5.5 Abbott Latest Developments

13.6 Bristol-Myers Squibb

13.6.1 Bristol-Myers Squibb Company Information

13.6.2 Bristol-Myers Squibb Pediatric Medicines Product Offered

13.6.3 Bristol-Myers Squibb Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bristol-Myers Squibb Main Business Overview

13.6.5 Bristol-Myers Squibb Latest Developments

13.7 Cipla

13.7.1 Cipla Company Information

13.7.2 Cipla Pediatric Medicines Product Offered

13.7.3 Cipla Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Cipla Main Business Overview

13.7.5 Cipla Latest Developments

13.8 Eisai Pharmaceuticals

13.8.1 Eisai Pharmaceuticals Company Information

13.8.2 Eisai Pharmaceuticals Pediatric Medicines Product Offered

13.8.3 Eisai Pharmaceuticals Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Eisai Pharmaceuticals Main Business Overview

13.8.5 Eisai Pharmaceuticals Latest Developments

13.9 Eli Lilly

13.9.1 Eli Lilly Company Information

13.9.2 Eli Lilly Pediatric Medicines Product Offered

13.9.3 Eli Lilly Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Eli Lilly Main Business Overview

13.9.5 Eli Lilly Latest Developments

13.10 F. Hoffman-La Roche

13.10.1 F. Hoffman-La Roche Company Information

13.10.2 F. Hoffman-La Roche Pediatric Medicines Product Offered

13.10.3 F. Hoffman-La Roche Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 F. Hoffman-La Roche Main Business Overview

13.10.5 F. Hoffman-La Roche Latest Developments

13.11 Glenmark

13.11.1 Glenmark Company Information

13.11.2 Glenmark Pediatric Medicines Product Offered

13.11.3 Glenmark Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Glenmark Main Business Overview

13.11.5 Glenmark Latest Developments

13.12 Helsinn Healthcare

13.12.1 Helsinn Healthcare Company Information

13.12.2 Helsinn Healthcare Pediatric Medicines Product Offered

13.12.3 Helsinn Healthcare Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Helsinn Healthcare Main Business Overview

13.12.5 Helsinn Healthcare Latest Developments

13.13 Heron Therapeutics

13.13.1 Heron Therapeutics Company Information

13.13.2 Heron Therapeutics Pediatric Medicines Product Offered

13.13.3 Heron Therapeutics Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Heron Therapeutics Main Business Overview

13.13.5 Heron Therapeutics Latest Developments

13.14 Ipca Laboratories

13.14.1 Ipca Laboratories Company Information

13.14.2 Ipca Laboratories Pediatric Medicines Product Offered

13.14.3 Ipca Laboratories Pediatric Medicines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Ipca Laboratories Main Business Overview

13.14.5 Ipca Laboratories Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Pediatric Medicines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pediatric Medicines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Enteral

Table 4. Major Players of Parenteral

Table 5. Major Players of Topical

Table 6. Global Pediatric Medicines Sales by Type (2017-2022) & (K Units)

Table 7. Global Pediatric Medicines Sales Market Share by Type (2017-2022)

Table 8. Global Pediatric Medicines Revenue by Type (2017-2022) & ($ million)

Table 9. Global Pediatric Medicines Revenue Market Share by Type (2017-2022)

Table 10. Global Pediatric Medicines Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Pediatric Medicines Sales by Application (2017-2022) & (K Units)

Table 12. Global Pediatric Medicines Sales Market Share by Application (2017-2022)

Table 13. Global Pediatric Medicines Revenue by Application (2017-2022)

Table 14. Global Pediatric Medicines Revenue Market Share by Application (2017-2022)

Table 15. Global Pediatric Medicines Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Pediatric Medicines Sales by Company (2020-2022) & (K Units)

Table 17. Global Pediatric Medicines Sales Market Share by Company (2020-2022)

Table 18. Global Pediatric Medicines Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Pediatric Medicines Revenue Market Share by Company (2020-2022)

Table 20. Global Pediatric Medicines Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Pediatric Medicines Producing Area Distribution and Sales Area

Table 22. Players Pediatric Medicines Products Offered

Table 23. Pediatric Medicines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Pediatric Medicines Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Pediatric Medicines Sales Market Share Geographic Region (2017-2022)

Table 28. Global Pediatric Medicines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Pediatric Medicines Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Pediatric Medicines Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Pediatric Medicines Sales Market Share by Country/Region (2017-2022)

Table 32. Global Pediatric Medicines Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Pediatric Medicines Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Pediatric Medicines Sales by Country (2017-2022) & (K Units)

Table 35. Americas Pediatric Medicines Sales Market Share by Country (2017-2022)

Table 36. Americas Pediatric Medicines Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Pediatric Medicines Revenue Market Share by Country (2017-2022)

Table 38. Americas Pediatric Medicines Sales by Type (2017-2022) & (K Units)

Table 39. Americas Pediatric Medicines Sales Market Share by Type (2017-2022)

Table 40. Americas Pediatric Medicines Sales by Application (2017-2022) & (K Units)

Table 41. Americas Pediatric Medicines Sales Market Share by Application (2017-2022)

Table 42. APAC Pediatric Medicines Sales by Region (2017-2022) & (K Units)

Table 43. APAC Pediatric Medicines Sales Market Share by Region (2017-2022)

Table 44. APAC Pediatric Medicines Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Pediatric Medicines Revenue Market Share by Region (2017-2022)

Table 46. APAC Pediatric Medicines Sales by Type (2017-2022) & (K Units)

Table 47. APAC Pediatric Medicines Sales Market Share by Type (2017-2022)

Table 48. APAC Pediatric Medicines Sales by Application (2017-2022) & (K Units)

Table 49. APAC Pediatric Medicines Sales Market Share by Application (2017-2022)

Table 50. Europe Pediatric Medicines Sales by Country (2017-2022) & (K Units)

Table 51. Europe Pediatric Medicines Sales Market Share by Country (2017-2022)

Table 52. Europe Pediatric Medicines Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Pediatric Medicines Revenue Market Share by Country (2017-2022)

Table 54. Europe Pediatric Medicines Sales by Type (2017-2022) & (K Units)

Table 55. Europe Pediatric Medicines Sales Market Share by Type (2017-2022)

Table 56. Europe Pediatric Medicines Sales by Application (2017-2022) & (K Units)

Table 57. Europe Pediatric Medicines Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Pediatric Medicines Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Pediatric Medicines Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Pediatric Medicines Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Pediatric Medicines Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Pediatric Medicines Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Pediatric Medicines Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Pediatric Medicines Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Pediatric Medicines Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Pediatric Medicines

Table 67. Key Market Challenges & Risks of Pediatric Medicines

Table 68. Key Industry Trends of Pediatric Medicines

Table 69. Pediatric Medicines Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Pediatric Medicines Distributors List

Table 72. Pediatric Medicines Customer List

Table 73. Global Pediatric Medicines Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Pediatric Medicines Sales Market Forecast by Region

Table 75. Global Pediatric Medicines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Pediatric Medicines Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Pediatric Medicines Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Pediatric Medicines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Pediatric Medicines Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Pediatric Medicines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Pediatric Medicines Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Pediatric Medicines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Pediatric Medicines Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Pediatric Medicines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Pediatric Medicines Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Pediatric Medicines Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Pediatric Medicines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Pediatric Medicines Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Pediatric Medicines Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Pediatric Medicines Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Pediatric Medicines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Pediatric Medicines Revenue Market Share Forecast by Application (2023-2028)

Table 93. GSK Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 94. GSK Pediatric Medicines Product Offered

Table 95. GSK Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. GSK Main Business

Table 97. GSK Latest Developments

Table 98. Novartis Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 99. Novartis Pediatric Medicines Product Offered

Table 100. Novartis Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Novartis Main Business

Table 102. Novartis Latest Developments

Table 103. Pfizer Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 104. Pfizer Pediatric Medicines Product Offered

Table 105. Pfizer Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Pfizer Main Business

Table 107. Pfizer Latest Developments

Table 108. Sanofi Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 109. Sanofi Pediatric Medicines Product Offered

Table 110. Sanofi Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Sanofi Main Business

Table 112. Sanofi Latest Developments

Table 113. Abbott Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 114. Abbott Pediatric Medicines Product Offered

Table 115. Abbott Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Abbott Main Business

Table 117. Abbott Latest Developments

Table 118. Bristol-Myers Squibb Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 119. Bristol-Myers Squibb Pediatric Medicines Product Offered

Table 120. Bristol-Myers Squibb Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Bristol-Myers Squibb Main Business

Table 122. Bristol-Myers Squibb Latest Developments

Table 123. Cipla Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 124. Cipla Pediatric Medicines Product Offered

Table 125. Cipla Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Cipla Main Business

Table 127. Cipla Latest Developments

Table 128. Eisai Pharmaceuticals Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 129. Eisai Pharmaceuticals Pediatric Medicines Product Offered

Table 130. Eisai Pharmaceuticals Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Eisai Pharmaceuticals Main Business

Table 132. Eisai Pharmaceuticals Latest Developments

Table 133. Eli Lilly Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 134. Eli Lilly Pediatric Medicines Product Offered

Table 135. Eli Lilly Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Eli Lilly Main Business

Table 137. Eli Lilly Latest Developments

Table 138. F. Hoffman-La Roche Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 139. F. Hoffman-La Roche Pediatric Medicines Product Offered

Table 140. F. Hoffman-La Roche Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. F. Hoffman-La Roche Main Business

Table 142. F. Hoffman-La Roche Latest Developments

Table 143. Glenmark Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 144. Glenmark Pediatric Medicines Product Offered

Table 145. Glenmark Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. Glenmark Main Business

Table 147. Glenmark Latest Developments

Table 148. Helsinn Healthcare Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 149. Helsinn Healthcare Pediatric Medicines Product Offered

Table 150. Helsinn Healthcare Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. Helsinn Healthcare Main Business

Table 152. Helsinn Healthcare Latest Developments

Table 153. Heron Therapeutics Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 154. Heron Therapeutics Pediatric Medicines Product Offered

Table 155. Heron Therapeutics Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 156. Heron Therapeutics Main Business

Table 157. Heron Therapeutics Latest Developments

Table 158. Ipca Laboratories Basic Information, Pediatric Medicines Manufacturing Base, Sales Area and Its Competitors

Table 159. Ipca Laboratories Pediatric Medicines Product Offered

Table 160. Ipca Laboratories Pediatric Medicines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 161. Ipca Laboratories Main Business

Table 162. Ipca Laboratories Latest Developments

List of Figures

Figure 1. Picture of Pediatric Medicines

Figure 2. Pediatric Medicines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pediatric Medicines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Pediatric Medicines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pediatric Medicines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Enteral

Figure 10. Product Picture of Parenteral

Figure 11. Product Picture of Topical

Figure 12. Global Pediatric Medicines Sales Market Share by Type in 2021

Figure 13. Global Pediatric Medicines Revenue Market Share by Type (2017-2022)

Figure 14. Pediatric Medicines Consumed in Hospital

Figure 15. Global Pediatric Medicines Market: Hospital (2017-2022) & (K Units)

Figure 16. Pediatric Medicines Consumed in Clinic

Figure 17. Global Pediatric Medicines Market: Clinic (2017-2022) & (K Units)

Figure 18. Pediatric Medicines Consumed in Family

Figure 19. Global Pediatric Medicines Market: Family (2017-2022) & (K Units)

Figure 20. Global Pediatric Medicines Sales Market Share by Application (2017-2022)

Figure 21. Global Pediatric Medicines Revenue Market Share by Application in 2021

Figure 22. Pediatric Medicines Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Pediatric Medicines Revenue Market Share by Company in 2021

Figure 24. Global Pediatric Medicines Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Pediatric Medicines Revenue Market Share by Geographic Region in 2021

Figure 26. Global Pediatric Medicines Sales Market Share by Region (2017-2022)

Figure 27. Global Pediatric Medicines Revenue Market Share by Country/Region in 2021

Figure 28. Americas Pediatric Medicines Sales 2017-2022 (K Units)

Figure 29. Americas Pediatric Medicines Revenue 2017-2022 ($ Millions)

Figure 30. APAC Pediatric Medicines Sales 2017-2022 (K Units)

Figure 31. APAC Pediatric Medicines Revenue 2017-2022 ($ Millions)

Figure 32. Europe Pediatric Medicines Sales 2017-2022 (K Units)

Figure 33. Europe Pediatric Medicines Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Pediatric Medicines Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Pediatric Medicines Revenue 2017-2022 ($ Millions)

Figure 36. Americas Pediatric Medicines Sales Market Share by Country in 2021

Figure 37. Americas Pediatric Medicines Revenue Market Share by Country in 2021

Figure 38. United States Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Pediatric Medicines Sales Market Share by Region in 2021

Figure 43. APAC Pediatric Medicines Revenue Market Share by Regions in 2021

Figure 44. China Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Pediatric Medicines Sales Market Share by Country in 2021

Figure 51. Europe Pediatric Medicines Revenue Market Share by Country in 2021

Figure 52. Germany Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Pediatric Medicines Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Pediatric Medicines Revenue Market Share by Country in 2021

Figure 59. Egypt Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Pediatric Medicines Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Pediatric Medicines in 2021

Figure 65. Manufacturing Process Analysis of Pediatric Medicines

Figure 66. Industry Chain Structure of Pediatric Medicines

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390